66 related articles for article (PubMed ID: 15829329)
41. Understanding Survival Analysis in Clinical Trials.
Emmerson J; Brown JM
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):12-14. PubMed ID: 32788065
[No Abstract] [Full Text] [Related]
42. The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases.
Chiang Y; Yang JC; Hsu FM; Chen YH; Shih JY; Lin ZZ; Lan KH; Cheng AL; Kuo SH
PLoS One; 2015; 10(12):e0145936. PubMed ID: 26720170
[TBL] [Abstract][Full Text] [Related]
43. Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size.
Lin ZZ; Shau WY; Hsu C; Shao YY; Yeh YC; Kuo RN; Hsu CH; Yang JC; Cheng AL; Lai MS
PLoS One; 2013; 8(11):e80276. PubMed ID: 24244668
[TBL] [Abstract][Full Text] [Related]
44. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
[TBL] [Abstract][Full Text] [Related]
45. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
Huber RM; Flentje M; Schmidt M; Pöllinger B; Gosse H; Willner J; Ulm K;
J Clin Oncol; 2006 Sep; 24(27):4397-404. PubMed ID: 16983107
[TBL] [Abstract][Full Text] [Related]
46. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
Wakelee HA; Bernardo P; Johnson DH; Schiller JH
Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
[TBL] [Abstract][Full Text] [Related]
47. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
[TBL] [Abstract][Full Text] [Related]
48. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A
Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655
[TBL] [Abstract][Full Text] [Related]
49. Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials.
Kuo SH; Yang CH; Yu CJ; Hsu C; Cheng AL; Yang PC
Lung Cancer; 2005 May; 48(2):275-80. PubMed ID: 15829329
[TBL] [Abstract][Full Text] [Related]
50. [Is it still allowable in 1994 to sanction therapeutic abstention for stage IIIB and IV non-small-cell bronchial cancer?].
Souquet PJ; Lombard-Bohas CH; Bernard JP
Rev Mal Respir; 1995; 12(1):71-2. PubMed ID: 7899675
[No Abstract] [Full Text] [Related]
51. [Role of chemotherapy in the treatment of advanced stage non-small-cell bronchial cancer].
Sculier JP
Rev Mal Respir; 1993; 10(4):287-9. PubMed ID: 8235020
[No Abstract] [Full Text] [Related]
52. [Perioperative chemotherapy for early-stage disease: an extra chance for the patient?].
Milleron B; Lavolé A
Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S3-7. PubMed ID: 15211225
[No Abstract] [Full Text] [Related]
53. [Criteria of choice for first-line chemotherapy for Stage IV disease].
Fournel P
Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S8-4S12. PubMed ID: 15687986
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
